The Trump administration signaled Medicare drug price negotiations under the Inflation Reduction Act (IRA) signed in 2022 by ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug ...

In August 2023, CMS identified the first 10 drugs for price negotiation. In August 2024, CMS announced the new prices for these drugs, which are slated to take effect in 2026. The pharmaceutical ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

President Trump is likely to embrace the Medicare drug price negotiations that was initiated under the Biden administration, though the president could make some tweaks to put his own spin on it.

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug price negotiation program enacted under President Joe Biden.

Records show that drug companies gave nearly $75,000 to the top Republican and Democrat on a committee investigating them.

The court ruled that Novartis is not legally compelled to participate in the Medicare Drug Price Negotiation Program. The decision reaffirmed that the program does not constitute excessive fines ...

Three Democratic senators want answers from Health and Human Services Secretary Robert F. Kennedy Jr. about his private meetings with drugmakers alongside President Trump at his Mar-a-Lago club in ...

The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs. Read more here.

Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...